UCP2 and cancer: In line with these concepts, the discovery that UCP2 is a C4-metabolite carrier that facilitates the export of malate, oxaloacetate, and aspartate from the mitochondrial matrix seems to provide a mechanistic explanation for the role of UCP2 in the metabolic adaptations of cancer cells [9].